BIOCQ.US Biocept Inc.

Healthcare Biotechnology USA Stocks
0.0002 USD
Close of Nov 13, 2026
0.0001 0.0020
Market cap
USD 525.00
P/E
-
P/B
0.29x
ROE
-7,431.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is BIOCQ.US undervalued?

Graham number

The Graham number of Biocept Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biocept Inc. fundamental analysis

No fundamental analysis for Biocept Inc. yet.

Biocept Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biocept Inc.

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resis…

Full company profile